More News

03 Mar 2017 Boehringer Ingelheim expands collaboration with Vanderbilt University to tackle some of the most difficult-to-treat cancers
03 Mar 2017 Otsuka Pharmaceutical to Acquire Neurovance, Inc.
03 Mar 2017 MedImmune and Sanofi Pasteur form alliance to develop and commercialise potential next-generation respiratory syncytial virus antibody MEDI8897
02 Mar 2017 Synthon enters worldwide exclusive license and collaboration with Sanquin for immuno-oncology therapeutic leads modulating the CD47-SIRPα pathway
01 Mar 2017 Invenra and QIMR Berghofer Medical Research Institute Enter Collaboration to Discover Therapeutic Antibodies Against Novel Target
28 Feb 2017 Exelixis Announces Clinical Trial Collaboration with Roche to Evaluate Cabozantinib and Atezolizumab in Locally Advanced or Metastatic Solid Tumors
28 Feb 2017 Helix BioPharma Corp. Announces Licence for Worldwide Right to Anti-CEACAM6 Antibody From the Government of Canada
28 Feb 2017 Advaxis and SELLAS Announce Licensing Agreement for Development of WT1 Antigen-Targeting Immunotherapy
28 Feb 2017 Pieris Signs 1st Partnership for Anemia Drug PRS-080, Granting Exclusive Option in Japan to ASKA Pharmaceutical
28 Feb 2017 Bushu and Takeda Announce Transformational Pharmaceutical Sciences Partnership
27 Feb 2017 Sanofi and Lonza Enter into a Strategic Partnership to Establish a Large-Scale Biologics Production Facility
27 Feb 2017 MolMed and Rocket Pharma establish a collaboration agreement in the field of gene therapy for the treatment of Fanconi Anemia
23 Feb 2017 Finch Therapeutics Announces Strategic Collaboration with OpenBiome to Develop Microbiome Therapies for FDA Approval
23 Feb 2017 Incyte Announces Oncology Research Alliance with the Abramson Cancer Center at the University of Pennsylvania
17 Feb 2017 Amygdala Neurosciences Acquires GS-6637 from Gilead Sciences
15 Feb 2017 Signum Biosciences Receives $3.0M Phase IIB SBIR Grant for the Development of SIG1451, A Novel Therapeutic for Atopic Dermatitis
15 Feb 2017 Boehringer Ingelheim and Weill Cornell Medicine announce new collaboration to discover next generation COPD treatments
15 Feb 2017 Incyte and Agenus Amend Collaboration Agreement
14 Feb 2017 AMAG and Endoceutics Enter Into an Exclusive U.S. License Agreement for Intrarosa™ (Prasterone)
13 Feb 2017 RedHill Biopharma Announces Enrollment of Last Patient in BEKINDA® Phase III Study for Acute Gastroenteritis
13 Feb 2017 Inovio and ApolloBio to Collaborate on Development and Commercialization of HPV Pre-cancer Immunotherapy VGX-3100 in Greater China
13 Feb 2017 Allergan to Acquire ZELTIQ, Best-in-Class Company in Fast-Growing Body Contouring Segment, for $2.47 Billion
13 Feb 2017 Akebia Licenses Portfolio of Novel HIF Compounds from Johnson & Johnson Innovation
13 Feb 2017 Ferring and Foresee Pharmaceuticals Enter into Exclusive Development and Option Agreement
11 Feb 2017 Immunomedics Enters into Exclusive Global Licensing Agreement with Seattle Genetics for Sacituzumab Govitecan (IMMU-132) with Potential Payments of up to Approximately $2 Billion, Plus Royalties

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing